Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study is a research paper published in Journal of Personalized Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1U01HL10222
National Institutes of Health
Grant: T32AI007306-33, AI078908, HL11113, HL117945, R37AI052353, R01AI136041, R01HL136209, R01AI130109, U19AO095219, K23AI118804
NHLBI NIH HHS
Grant: U01 HL102225
National Institutes of Health
Grant: 5T32AI007306-10
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITY
National Institutes of Health
Grant: 1R01HL117945-01
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
National Institutes of Health
Grant: 5R01HL136209-04
Optimizing EP receptor subtype targeting for asthma therapy
National Institutes of Health
Grant: 5U19AI095219-04
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*
National Institutes of Health
Grant: 5R01AI136041-08
Eicosanoid Networks in Aspirin Hypersensitivity
National Institutes of Health
Grant: 1U01HL102225-01
Ancillary Study
National Institutes of Health
Grant: 5R37AI052353-17
CysLT and P2Y Receptors in Lung Inflammation
National Institutes of Health
Grant: 5K23AI118804-03
The Role of Prostaglandin D2 in the Respiratory Symptoms of Aspirin Exacerbated Respiratory Disease
National Institutes of Health
Grant: 2R01AI078908-07A1
Regulation of Pulmonary Inflammation by Leukotriene E4
FWCI
0.57
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals